NEW DELHI: With preparations underway for a potential vaccine launch in January, India’s drug regulator is looking to the UK, which sources say may give the Oxford Covid-19 vaccine its go-ahead next week , before deciding to grant an emergency use authorization to the Serum Institute that manufactures the injections …
Read More »
NEW DELHI: Trade and investment with UK Pushing India for a free trade agreement, alongside Indo-Pacific, defense and security and early recovery cooperation from Covid-19, dominated the agenda of Tuesday’s meeting between the UK’s secretary of state for foreign affairs, Dominic Raab, and his counterpart S Jaishankar. Raab, the second …
Read More »
NEW DELHI: India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidates, which the firm says is 62% effective and not the “more complete half” dose regimen, which is claimed to be up to 90% effective, but has drawn criticism for dosing errors. the Indian governmentThe …
Read More »
NEW DELHI: India’s central drug regulator issued a notice to the Pune-based Serum Institute of India (SII) on Wednesday, asking why the company had failed to inform it of the “reported serious adverse events” that led to UK partner AstraZeneca to “temporarily pause” global clinical trials of the Oxford Covid …
Read More »